Table 4 |
|||||
|
Meta-analysis of all trials and high-quality trials from evidence-based practice guidelines |
|||||
|
Practice Guideline |
|||||
|
|
|||||
|
Colon Cancer Adjuvant chemotherapy Outcome: Mortality (32) |
Head & Neck Concomitant therapy Outcome: Mortality (31) |
Systemic Therapy erythropoietin Outcome: need for blood transfusion (34) |
|||
|
|
|||||
|
All Studies |
# studies (# comparisons) |
11 (11) |
18 (20) |
15 (15) |
|
|
OR (CI) |
0.82 (0.62 – 1.09) |
0.62 (0.54 – 0.72) |
0.57 (0.47–0.70) |
||
|
High Quality Studies By Assessment Scale Criteria |
Jadad (3-item) range = 0–5 criteria >2 |
# studies (# comparisons) |
0 |
2 (2) |
not applied |
|
OR (CI) |
- |
0.54 (0.34 – 0.86) |
|||
|
Jadad (6-item) range = 0–8 criteria >3 |
# studies (# comparisons) |
8 (8) |
13 (14) |
9 (9) |
|
|
OR (CI) |
0.88 (0.69–1.13) |
0.53 (0.44 – 0.64) |
0.57 (0.44–0.72) |
||
|
Sindhu (41-item) range = 0–79.5 criteria > 44.8 |
# studies (# comparisons) |
9 (9) |
11 (12) |
not applied |
|
|
OR (CI) |
0.86 (0.68–1.09) |
0.62 (0.49 – 0.79) |
|||
|
Downs & Black (13-item) range = 0–13 criteria > 7 |
# studies (# comparisons) |
6 (6) |
12 (14) |
not applied |
|
|
OR (CI) |
0.86 (0.59–1.25) |
0.56 (0.46 – 0.68) |
|||
|
|
|||||
|
OR, odds ratio; CI, 95% confidence interval |
|||||
|
Brouwers et al. BMC Medical Research Methodology 2005 5:8 doi:10.1186/1471-2288-5-8 |
|||||